Sickle Cell Disease study: Passive Immersive vs Active Immersive Interactive
Official title Virtual Reality for SCD VOC
ClinicalTrials.gov ID: NCT07674277
What this study is testing
- What it's testing
- This study will evaluate the feasibility, side effects, and preliminary analgesic effect of headset-based virtual reality (VR) interventions for adults with sickle cell disease (SCD) experiencing vaso-occlusive crisis (VOC) treated in an infusion center.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 88
You may be able to join if
- Participants will be identified, screened, and consented during routine outpatient sickle cell disease clinic visits when they are clinically stable...
- Adult patients aged 18 years or older.
- History of sickle cell disease.
- Treatment plan by the clinical care team includes intravenous opioids for acute pain.
- Receiving treatment through the Stoler Infusion Center. \ \
You likely can't join if
- Prior enrollment in this study.
- Presentation with a chief complaint suggestive of a complicated vaso-occlusive crisis, including concern for acute chest syndrome, splenic...
- Not receiving intravenous opioids for the vaso-occlusive crisis.
- Inability to provide informed consent.
- Medical history of seizures or known intolerance to virtual reality devices.
- Preexisting visual or hearing impairments that, in the investigator's judgment, preclude use of a head-mounted virtual reality device.
See the full eligibility criteria
- Participants will be identified, screened, and consented during routine outpatient sickle cell disease clinic visits when they are clinically stable and not experiencing an acute vaso-occlusive crisis (VOC).
- Adult patients aged 18 years or older.
- History of sickle cell disease.
- Treatment plan by the clinical care team includes intravenous opioids for acute pain.
- Receiving treatment through the Stoler Infusion Center. \ \
- Prior enrollment in this study.
- Presentation with a chief complaint suggestive of a complicated vaso-occlusive crisis, including concern for acute chest syndrome, splenic sequestration, hepatic sequestration, or pulmonary embolism, as determined by...
- Not receiving intravenous opioids for the vaso-occlusive crisis.
- Inability to provide informed consent.
- Medical history of seizures or known intolerance to virtual reality devices.
- Preexisting visual or hearing impairments that, in the investigator's judgment, preclude use of a head-mounted virtual reality device.
- Known pregnancy.
- Incarceration at the time of evaluation.
- Age greater than 88 years.
The study team makes the final eligibility decision.
Where it is enrolling
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 88 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Baltimore, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.